In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research
{{output}}
Peptide hormone-based weight-loss therapeutics have gained increasing attention, driven amongst other reasons, by the clinical and commercial success of semaglutide. Their increasing accessibility raises concerns about their potential misuse in sports, especia... ...
